Biopharma Co. Leads Pack Of 5 IPOs Totaling $650.8M

Law360 (October 9, 2020, 6:21 PM EDT) -- A Cooley-steered biopharmaceutical company developing cancer therapies led a pack of five operating companies whose shares debuted in the U.S. Friday in initial public offerings that totaled $650.8 million.

San Mateo, California-based Kronos Bio Inc. said it raised $250 million to fund clinical trials and develop new therapies, making it the largest of the pack of operating companies that went public. Two biotechnology companies also debuted, showing that life science companies are still dominating the IPO market. A Chinese provider of educational entertainment products for children and a security software company brought up the rear of the pack.

Of the floats...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!